Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
. 2014;88(1):3-15.
doi: 10.1159/000363390. Epub 2014 May 27.

New Inhaler Devices - The Good, the Bad and the Ugly


New Inhaler Devices - The Good, the Bad and the Ugly

Federico Lavorini et al. Respiration. .


Drug delivery to the lungs is an effective way of targeting inhaled therapeutic aerosols and treating obstructive airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD). In the past 10 years, several new drugs for the management of asthma and COPD have been marketed and more are under development. These new therapeutic respiratory drugs have been furthered by innovations in all categories of pulmonary drug delivery systems to ensure optimal aerosolisation performance, consistency in efficacy and satisfactory patient adherence. In this review, we discuss the technological advances and innovations in recent inhaler devices and the evolving roles of pressurised metered-dose inhalers, dry powder inhalers and nebulisers, as well as their impact on patient adherence to treatment.

Similar articles

See all similar articles

Cited by 31 articles

See all "Cited by" articles

Publication types